Introduction In pharma, competitive advantage depends on information—who knows what first, and who acts on…
Browsing: Latest Hotspot
Learn all about the important new features and changes in Eureka,Our latest product enhancements help you discover prospects and act on accounts faster.
Introduction In drug discovery and investment, not all drug candidates are created equal. Some compounds…
Introduction Pharma licensing deals often involve hundreds of millions—or even billions—of dollars. Yet, behind every…
Introduction Investing in biotech is fundamentally different from investing in other industries. The value of…
Introduction Evaluating a drug pipeline is one of the most important responsibilities for business development…
Why Tech Due Diligence Is the Bottleneck In biotech and pharma, technical due diligence is…
Patent analysis is critical—but painfully slow. The real question is: Should you still rely on…
Pharma competitive intelligence (CI) is no longer optional. It directly impacts: ❗ The Challenge CI…
In biotech, speed is everything. If your competitor identifies a promising drug candidate before you…
Understanding drug molecules from patents is critical in: But extracting molecular insights from patents is…